Clinical Efficacy Of Postauricular Injection Of Corticosteroid And Lidocaine For Tinnitus

Objectives This research observes clininal efficacy of postauricular injection of corticosterioid and lidocaine under the mastoid bond for subjective tinnitus and explores the clinical effective method in the treatment of tinnitus.Methods One hundred and fourteen patients with tinnitus as their first complaint to the Affiliated Hospital of North China University of Science and Technology from October 2014 to November 2015, including 59 males and 55 females, aged 22 to 65 years old,35 acute tinnitus patients,49 subacute tinnitus patients and 30 chronic tinnitus patients were selected as subjects. They were randomly divided into three groups:Group A, Group B and Group C, each with 38 cases. Group A (experimental group) was treated with oral vitamin B1 and mecobalamin tablets, and at the same time with postauricular injection of corticosterioid and lidocaine under the mastoid bone (treatment method: postauricular injection of 2% lidocaine and methylprednisolone sodium succinate lml, every other day,5 times for one course); Group B was treated with oral vitamin B1 and mecobalamin tablets, and at the same time with postauricular injection of NS under the mastoid bone; Group C was treated with oral vitamin B1 and mecobalamin tablets. All patients were instructed to have a good rest and keep a good mood. All 114 cases in accordance with the inclusion criteria were asked by the same physician to fill in TEQ before accepting treatment and one month after one treatment course respectively, by which to evaluate the change and efficacy of subjective tinnitus before and after treatment. The efficacy is divided into cured, markedly effective, effective and ineffective. Cured, markedly effective, effective all belong to effective category.Results 1. Patients TEQ scores of three groups before treatment were analyzed and compared,P>0.05, indicating that there were no significant difference between patients TEQ scores of three groups before treatment.2. Patients TEQ scores of three groups after treatment were ranked. TEQ scores of Group A and Group B were analyzed and compared, P<0.05, indicating that there were significant difference, TEQ scores of Group A lower than Group B; TEQ scores of Group A and Group C were analyzed and compared, P<0.05, indicating that there were significant difference, TEQ scores of Group A lower than Group C; TEQ scores of Group B and Group C were analyzed and compared,P>0.05, indicating that there were no significant difference.3. In Group A, the clinical total efficiency rate is 68.42%; In Group B, the clinical total efficiency rate is 39.47%; and in Group C, the clinical total efficiency rate is 34.21%. The total effective rate of Group A in treating subjective tinnitus was significantly higher than that of Group B and C; the total effective rate of Group B was a little higher than that of Group C.4. In Group A, acute tinnitus the total efficiency rate is 100%; subacute tinnitus the total efficiency is 66.67%; chronic tinnitus the total efficiency rate is 25%. In Group B, acute tinnitus the total efficiency rate is 80%; subacute tinnitus the total efficiency is 43.75%; chronic tinnitus the total efficiency rate are 0. In Group C, acute tinnitus the total efficiency rate is 53.85%; subacute tinnitus the total efficiency is 40%; chronic tinnitus the total efficiency rate are 0. This research shows that the shorter tinnitus duration is, the better treatment will be.Conclusions The research results show that we can achieve significantly efficacy through postauricular injection of methylprednisolone and lidocaine under the mastoid bone in the treatment of subjective tinnitus. The result show shorter tinnitus duration, better treatment.